Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

Ageing reversal may be closer than we think – scientists have begun human trials to test anti-ageing methods.

It is well known that students who prepare in advance perform better in exams. Now, it appears that the skin can do the same.

Advances in iPSC technology and in vivo reprogramming are expanding the possibilities for cell therapy. Explore the science ...

A new technical paper, “Neural Computers,” was published by researchers at Meta AI and KAUST. Abstract “We propose a new ...

A burgeoning field is launching its first clinical trial to find out whether dialling back cell development can safely ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

Life Biosciences, a Boston longevity biotech co-founded by Harvard genetics professor David Sinclair, has locked down an $80 ...

Mineral casts of cancer cell surfaces reprogram fat cells into stem cells and improve insulin sensitivity in obese mice ...

HexemBio has launched with a seed round led by Draper Associates to advance a blood stem cell rejuvenation therapy backed by Robert Langer.

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...